Afatinib Market Key Drivers and Forecast 2025-2032
Afatinib Market Trends And Drivers The global Afatinib market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 6.3 Billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2% from 2024 to 2030. Afatinib, an EGFR inhibitor primarily used for treating non-small cell lung cancer (NSCLC), continues […]
Continue Reading